|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2002-6-5
|
|
pubmed:abstractText |
Paracetamol is widely recommended as the initial treatment for pain associated with osteoarthritis (OA). A sustained release (SR) paracetamol formulation (Panadol Extend) was compared with standard immediate release (IR) paracetamol (Panadol) in patients with knee pain secondary to OA. The primary parameter for assessment of efficacy was patient-assessed global pain relief as determined on day 8 of the treatment period.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/12047487-10222222,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12047487-10358691,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12047487-10990186,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12047487-11014340,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12047487-11087696,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12047487-11112243,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12047487-11319576,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12047487-11587503,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12047487-1403677,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12047487-2052056,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12047487-2054266,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12047487-3197368,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12047487-9588381
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0306-5251
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
53
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
629-36
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:12047487-Acetaminophen,
pubmed-meshheading:12047487-Administration, Oral,
pubmed-meshheading:12047487-Adult,
pubmed-meshheading:12047487-Aged,
pubmed-meshheading:12047487-Aged, 80 and over,
pubmed-meshheading:12047487-Analgesics,
pubmed-meshheading:12047487-Delayed-Action Preparations,
pubmed-meshheading:12047487-Dose-Response Relationship, Drug,
pubmed-meshheading:12047487-Double-Blind Method,
pubmed-meshheading:12047487-Female,
pubmed-meshheading:12047487-Humans,
pubmed-meshheading:12047487-Knee,
pubmed-meshheading:12047487-Male,
pubmed-meshheading:12047487-Middle Aged,
pubmed-meshheading:12047487-Osteoarthritis, Knee,
pubmed-meshheading:12047487-Patient Compliance
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Analgesic efficacy of sustained release paracetamol in patients with osteoarthritis of the knee.
|
|
pubmed:affiliation |
GlaxoSmithKline, St George's Avenue, Weybridge, Surrey KT13 0DE, UK. teresa.h.bacon@gsk.com
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Multicenter Study
|
